These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11332996)

  • 1. Integrating harm reduction therapy and traditional substance abuse treatment.
    Marlatt GA; Blume AW; Parks GA
    J Psychoactive Drugs; 2001; 33(1):13-21. PubMed ID: 11332996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridging the gap in San Francisco: the process of integrating harm reduction and traditional substance abuse services.
    Gleghorn A; Rosenbaum M; Garcia BA
    J Psychoactive Drugs; 2001; 33(1):1-7. PubMed ID: 11332995
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies for implementation of harm reduction in treatment settings.
    Denning P
    J Psychoactive Drugs; 2001; 33(1):23-6. PubMed ID: 11332997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving health and social care relationships for harm reduction.
    Allman D; Myers T; Schellenberg J; Strike C; Cockerill R; Cavalieri W
    Int J Drug Policy; 2007 May; 18(3):194-203. PubMed ID: 17689366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance use management: a harm reduction-principled approach to assisting the relief of drug-related problems.
    Bigg D
    J Psychoactive Drugs; 2001; 33(1):33-8. PubMed ID: 11332999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opening inspiration for "Bridging the gap: integrating traditional substance abuse and harm reduction services" (May 3-4, 1999, San Francisco).
    Sanders EC
    J Psychoactive Drugs; 2001; 33(1):9-12. PubMed ID: 11333006
    [No Abstract]   [Full Text] [Related]  

  • 7. Integrating harm reduction and abstinence-based substance abuse treatment in the public sector.
    Futterman R; Lorente M; Silverman S
    Subst Abus; 2004 Mar; 25(1):3-7. PubMed ID: 15201106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Training the next generation of providers in addiction medicine.
    Rasyidi E; Wilkins JN; Danovitch I
    Psychiatr Clin North Am; 2012 Jun; 35(2):461-80. PubMed ID: 22640766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceptability and availability of harm-reduction interventions for drug abuse in American substance abuse treatment agencies.
    Rosenberg H; Phillips KT
    Psychol Addict Behav; 2003 Sep; 17(3):203-10. PubMed ID: 14498814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New systems of care for substance use disorders: treatment, finance, and technology under health care reform.
    Pating DR; Miller MM; Goplerud E; Martin J; Ziedonis DM
    Psychiatr Clin North Am; 2012 Jun; 35(2):327-56. PubMed ID: 22640759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the acceptability of non-abstinence goals by type of drug among American substance abuse clinicians.
    Rosenberg H; Davis AK
    J Subst Abuse Treat; 2014 Feb; 46(2):214-8. PubMed ID: 23953169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harm reduction therapy with families and friends of people with drug problems.
    Denning P
    J Clin Psychol; 2010 Feb; 66(2):164-74. PubMed ID: 20049921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public stigma in health and non-healthcare students: attributions, emotions and willingness to help with adolescent self-harm.
    Law GU; Rostill-Brookes H; Goodman D
    Int J Nurs Stud; 2009 Jan; 46(1):107-18. PubMed ID: 18962601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing an integrated substance use and mental health service in the specialised setting of a youth detention centre.
    Stathis SL; Letters P; Doolan I; Whittingham D
    Drug Alcohol Rev; 2006 Mar; 25(2):149-55. PubMed ID: 16627304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards the integration of treatment systems for substance abusers: report on the second International Symposium on Substance Abuse Treatment and Special Target Groups.
    Broekaert E; Vanderplasschen W
    J Psychoactive Drugs; 2003; 35(2):237-45. PubMed ID: 12924746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance abuse treatment in the Commonwealth of Massachusetts: gaps, consequences and solutions.
    Brolin MF; Horgan C; Amaro H; Doonan M
    Issue Brief (Mass Health Policy Forum); 2005 Nov; (27):1-25. PubMed ID: 16302313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging the gap between research and drug abuse treatment.
    Sorensen JL; Midkiff EE
    J Psychoactive Drugs; 2000; 32(4):379-82. PubMed ID: 11210199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating Addictions: Harm Reduction in Clinical Care and Prevention.
    Drucker E; Anderson K; Haemmig R; Heimer R; Small D; Walley A; Wood E; van Beek I
    J Bioeth Inq; 2016 Jun; 13(2):239-49. PubMed ID: 27112489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study.
    Humphreys K; Moos R
    Alcohol Clin Exp Res; 2001 May; 25(5):711-6. PubMed ID: 11371720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug abuse treatment on demand in San Francisco: preliminary findings.
    Guydish J; Moore L; Gleghorn A; Davis T; Sears C; Harcourt J
    J Psychoactive Drugs; 2000; 32(4):363-70. PubMed ID: 11210197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.